| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 03/05/2013 | US8389677 Antioxidant polypeptide and a process for isolation and purification of the same |
| 02/28/2013 | WO2012166006A9 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof |
| 02/28/2013 | US20130053543 Peptide clearing agents |
| 02/28/2013 | US20130053541 Methods for discovering molecules that bind to proteins |
| 02/28/2013 | US20130053428 Natural antisense and non-coding rna transcripts as drug targets |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use |
| 02/27/2013 | CN102153619B Small molecular weight glycopeptide extracted from stiff silkworm as well as extraction separation method and application thereof |
| 02/27/2013 | CN101928742B Whey protein active peptide with antioxidant activity and preparation method thereof |
| 02/27/2013 | CN101712975B Deodorized fish peptide and preparation method thereof |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/21/2013 | US20130046076 Crystal Structure of Amino Terminal Portion of Influenza Virus Polymerase PA Subunit and Use thereof |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| 02/14/2013 | US20130041132 Chemical preparation of ubiquitin thioesters and modifications thereof |
| 02/14/2013 | US20130040894 Inhibition or activation of serine/threonine ulk3 kinase activity |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/13/2013 | CN102925524A Seafood leftover oligopeptide and preparation method thereof |
| 02/13/2013 | CN102925521A Soybean peptide capable of shortening ultrahigh-concentration beer fermentation period, preparation method and application thereof |
| 01/31/2013 | US20130029878 Method for Assaying Histone Methylation Enzyme Activity |
| 01/31/2013 | US20130029399 Metal salen complex derivative and process for production thereof |
| 01/31/2013 | US20130029358 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| 01/31/2013 | US20130028932 Compositions comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists |
| 01/31/2013 | US20130028900 Methods and compositions for the generation and use of conformation-specific antibodies |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361479 Promiscuous PAP CD4 T cell epitopes |
| 01/29/2013 | US8361476 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 01/24/2013 | US20130023460 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 01/24/2013 | US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 01/23/2013 | CN102887940A Bioactive peptide prepared from shellfish processing byproducts and preparation method thereof |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/17/2013 | WO2013009885A2 Evaluation of copolymer diethylamide |
| 01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
| 01/16/2013 | CN102875640A Method for extracting small-molecule peptides of spirulina |
| 01/15/2013 | US8354496 Isoforms of brain natriuretic peptide |
| 01/15/2013 | CA2489186C Chemical synthesis of reagents for peptide coupling |
| 01/10/2013 | US20130012571 Organic Compositions to Treat Beta-ENaC-Related Diseases |
| 01/10/2013 | US20130011916 Construction and use of transfection enhancer elements |
| 01/10/2013 | US20130011828 Use |
| 01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
| 01/09/2013 | CN102864199A Method for producing anti-oxidative polypeptide by using rice residue |
| 01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
| 01/03/2013 | WO2013001120A1 Chemical process for the selective modification of peptides |
| 01/03/2013 | US20130005661 Pharmaceutical compositions |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005642 Methods for recovering peptides/amino acids and oil/fat from one or more protein-containing raw materials, and products produced by the methods |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004492 Fgfr extracellular domain acidic region muteins |
| 01/03/2013 | DE102011105909A1 Prozess zur Herstellung eines Rapsproteinisolats Process for producing a Rapsproteinisolats |
| 01/02/2013 | CN102850430A Animal colostrum derived protein fragment and application thereof |
| 01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 01/01/2013 | US8343503 Contiguous overlapping peptides for treatment of birch pollen allergy |
| 01/01/2013 | US8343500 Peptide composition |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 12/27/2012 | US20120329987 Metal Abstraction Peptide (MAP) Tag and Associated Methods |
| 12/27/2012 | US20120329726 Hair Shape Susceptibility Gene |
| 12/27/2012 | US20120329129 Magnetic nanoparticle with biocompatibility |
| 12/27/2012 | US20120329062 Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Additional Quantifiable Extenders |
| 12/27/2012 | US20120328665 Composite nanoparticle, and preparation process and use thereof |
| 12/27/2012 | US20120328628 Antibodies to conformationally trapped proteins |
| 12/25/2012 | US8338380 Use of the peptide RFMWMR as a therapeutic agent |
| 12/25/2012 | US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes |
| 12/25/2012 | US8338363 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
| 12/20/2012 | US20120322975 Nucleic acids encoding antibodies that bind factor d |
| 12/20/2012 | US20120322974 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 12/20/2012 | US20120322726 Therapeutic agent for eating disorders |
| 12/20/2012 | US20120321635 Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer |
| 12/20/2012 | US20120321554 Plexin d1 as a target for tumor diagnosis and therapy |
| 12/19/2012 | CN101386638B A method for preparing protein extract from rice bran |
| 12/18/2012 | US8334253 Cosmetic and dermatological formulations of MNTF peptides |
| 12/13/2012 | US20120316119 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 12/11/2012 | US8329865 Antimicrobially active peptides |
| 12/11/2012 | US8329391 entail analysis of the pyro-glutamate (gyro-Glu) content of the glatiramer acetate in a sample; for multiple sclerosis |
| 12/11/2012 | CA2357037C Optical sorting method |
| 12/06/2012 | WO2012166006A1 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof |
| 12/06/2012 | WO2012166005A1 Protein-polypeptide complex with a specific activity on skin tissue, process for preparing same and pharmaceutical composition on the basis thereof |
| 12/06/2012 | WO2012166004A1 Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof |
| 12/06/2012 | WO2012163290A1 Pharmaceutical compositions |
| 12/06/2012 | US20120309684 Conjugates for delivery of biologically active compounds |
| 12/06/2012 | US20120308647 Use of mir-30e to treat vascular lesions |
| 12/06/2012 | US20120308598 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins |
| 11/29/2012 | WO2012159263A1 Enzyme-degradable polymer and application thereof |
| 11/29/2012 | US20120302731 Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof |
| 11/29/2012 | US20120302505 Cyclodextrin-based polymers for therapeutic delivery |
| 11/29/2012 | US20120302502 Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion |
| 11/29/2012 | US20120302453 Oxocarbonamide peptide nucleic acids and methods of using same |
| 11/29/2012 | US20120301535 Combination peptide-nanoparticles and delivery systems incorporating same |
| 11/29/2012 | US20120301492 Compositions and methods for wt1 specific immunotherapy |
| 11/29/2012 | US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc |
| 11/29/2012 | US20120301424 Cyclodextrin-based polymers for therapeutics delivery |
| 11/29/2012 | US20120301400 Meditopes and meditope-binding antibodies and uses thereof |
| 11/28/2012 | EP2526958A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 11/27/2012 | US8321143 Synthetic active peptide fragments |
| 11/22/2012 | WO2012155295A1 Industrial production method for producing antihypertensive bioactive peptide |
| 11/22/2012 | US20120297502 Method for improving plant tolerance to environmental stress |